This review article explores the role of calprotectin as a key biomarker in inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Elevated levels of calprotectin are closely associated with disease activity, making it an effective non-invasive marker for diagnosing IBD, assessing disease severity, monitoring treatment response, and predicting
